Atrion Corp (ATRI):企業の財務・戦略的SWOT分析

◆英語タイトル:Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0427
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Atrion Corp (ATRI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Atrion Corp (Atrion) develops and manufactures fluid delivery, cardiovascular, ophthalmic, and other medical and non-medical products. The company’s portfolio spans proprietary valves, silicone vessel loops, myocardial protection system, inflation devices, medical devices that disinfect contact lenses, balloon catheters, and products used in heart bypass surgery. Atrion also offers products for safe needle and scalpel blade containment, instrumentation and related disposables for measuring the clotting time of blood, inflation systems and valves for aviation and marine safety products, one-way and two-way pressure relief valves, and components used in inflatable survival products and structures. It sells its products to physicians, clinics, hospitals, and other treatment centers. It has subsidiaries in Delaware, Texas, and Alabama. Atrion is headquartered in Allen, Texas, the US.

Atrion Corp Key Recent Developments

Nov 01,2019: Atrion reports third quarter 2019 results
Aug 07,2019: Atrion reports second quarter results
May 08,2019: Atrion reports first quarter results
Feb 26,2019: Atrion announces fourth quarter and full year 2018 financial results
Nov 09,2018: Atrion reports third quarter results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Atrion Corp – Key Facts
Atrion Corp – Key Employees
Atrion Corp – Key Employee Biographies
Atrion Corp – Major Products and Services
Atrion Corp – History
Atrion Corp – Company Statement
Atrion Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Atrion Corp – Business Description
Product Category: Cardiovascular
Overview
Performance
Product Category: Fluid Delivery
Overview
Performance
Product Category: Ophthalmology
Overview
Performance
Product Category: Other
Overview
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other Countries Less than 5% of Revenue
Performance
Geographical Segment: The US
Performance
R&D Overview
Atrion Corp – SWOT Analysis
SWOT Analysis – Overview
Atrion Corp – Strengths
Atrion Corp – Weaknesses
Atrion Corp – Opportunities
Atrion Corp – Threats
Atrion Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Nov 01, 2019: Atrion reports third quarter 2019 results
Aug 07, 2019: Atrion reports second quarter results
May 08, 2019: Atrion reports first quarter results
Feb 26, 2019: Atrion announces fourth quarter and full year 2018 financial results
Nov 09, 2018: Atrion reports third quarter results
Aug 07, 2018: Atrion announces second quarter results
May 09, 2018: Atrion Reports First Quarter Results 2018
Feb 27, 2018: Atrion Announces Fourth Quarter and Full Year 2017 Financial Results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Atrion Corp, Key Facts
Atrion Corp, Key Employees
Atrion Corp, Key Employee Biographies
Atrion Corp, Major Products and Services
Atrion Corp, History
Atrion Corp, Subsidiaries
Atrion Corp, Key Competitors
Atrion Corp, Ratios based on current share price
Atrion Corp, Annual Ratios
Atrion Corp, Annual Ratios (Cont...1)
Atrion Corp, Annual Ratios (Cont...2)
Atrion Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Atrion Corp, Performance Chart (2014 - 2018)
Atrion Corp, Ratio Charts

★海外企業調査レポート[Atrion Corp (ATRI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JAFCO Co., Ltd.:企業のM&A・事業提携・投資動向
    JAFCO Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JAFCO Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Dentsply Sirona Inc (XRAY)-医療機器分野:企業M&A・提携分析
    Summary Dentsply Sirona Inc (Dentsply) formerly Dentsply International Inc. is a medical device company that designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic instrumen …
  • Medical Prognosis Institute A/S (MPI):企業の財務・戦略的SWOT分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • JA Solar Holdings Co Ltd (JASO):企業の財務・戦略的SWOT分析
    JA Solar Holdings Co Ltd (JASO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Endologix Inc (ELGX):医療機器:M&Aディール及び事業提携情報
    Summary Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA p …
  • Ping An Insurance (Group) Company of China, Ltd.:企業のM&A・事業提携・投資動向
    Ping An Insurance (Group) Company of China, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ping An Insurance (Group) Company of China, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • ARRIS International PLC:企業の戦略的SWOT分析
    ARRIS International PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223):医療機器:M&Aディール及び事業提携情報
    Summary Jiangsu Yuyue Medical Equipment & Supply Co Ltd (Jiangsu Yuyue) is a medical device company that manufactures and distributes various medical equipments. The company’s products include electronic blood pressure monitor, air sterilization purifier, X-ray machine, blood glucose meter, temperat …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Siluria Technologies Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Siluria Technologies Inc (Siluria) engaged in producing fuels and chemicals from natural gas and low value byproducts. Its products include modus - olefins to gasoline, and gemini - natural gas to ethylene. The company also involved in catalytic process to convert natural gas into liquid fue …
  • Simcere Pharmaceutical Group-製薬・医療分野:企業M&A・提携分析
    Summary Simcere Pharmaceutical Group (Simcere) is a drug discovery company that manufactures and supplies branded generic and prescription pharmaceutical products. The company offers products in therapeutic areas including anti-tumor, central nervous, anti-infection, cardiovascular, skeletal muscle, …
  • Verge Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Verge Genomics Inc (Verge Genomics) is a drug discovery company that focuses on the discovery of treatments for neurodegenerative diseases using human genomic data and machine learning. The company combines large-scale molecular, genomic and genetic data on multiple platforms and technologie …
  • Abeome Corp-製薬・医療分野:企業M&A・提携分析
    Summary Abeome Corp (Abeome) is a biotechnology company that discovers diagnostic monoclonal antibodies and therapeutic antibodies. The company's pipeline components include PCSK9 to treat hypercholesterolemia; IL-17A to treat psoriasis and inflammation diseases, IL-17F to treat autoimmune diseases, …
  • International Drug Development Institute-製薬・医療分野:企業M&A・提携分析
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and …
  • Royal Caribbean Cruises Ltd.:戦略・SWOT・企業財務分析
    Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report Summary Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Alliance Healthcare Services Inc:企業の戦略的SWOT分析
    Alliance Healthcare Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Kadmon Holdings Inc (KDMN):製薬・医療:M&Aディール及び事業提携情報
    Summary Kadmon Holdings Inc (Kadmon) is an integrated biopharmaceutical company that discovers, develops and markets small molecules and biologics for autoimmune and fibrotic diseases, various types of cancer, and genetic diseases. The company’s pipeline encompasses investigational candidates for th …
  • Michelin SCA (ML):企業の財務・戦略的SWOT分析
    Michelin SCA (ML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Habib Metropolitan Bank Limited:企業の戦略・SWOT・財務分析
    Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hecla Mining Company
    Hecla Mining Company - Strategy, SWOT and Corporate Finance Report Summary Hecla Mining Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆